Clinical Trial

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

Study acronym: MAP-IBD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main questions it aims to answer are: Are microplastics detectable in different biological samples from children? Are there differences in microplastic burden between children with and without IBD? Researchers will collect biological samples including: intestinal tissue (from routine endoscopy), stool, urine, blood. Raman spectroscopy will be used to detect and characterize microplastics in each sample type. Participants will not receive any medication or intervention as part of this study. All samples will be collected during standard clinical procedures.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-18.
Trial Details
NCT Number NCT07141238
Lead Sponsor Medical University of Gdansk
Conditions Crohn Disease, Pediatric Inflammatory Bowel Diseases, Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD)
Enrollment 40 participants
Start Date 2025-06-15
Primary Completion 2025-12 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-09-30